Zobrazeno 1 - 10
of 11
pro vyhledávání: '"LBS Gelinck"'
Autor:
N Roescher, JM Prins, JTM van der Meer, HI Bax, R Soetekouw, MGJ de Boer, LBS Gelinck, JJ Oosterheert, MA van Agtmael, M Berrevoets, DTP Buis, CH van Werkhoven, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, E Jong, AJJ Lammers, E Sieswerda, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, KCE Sigaloff, E Botman, A Van den Broek, L Buitenhuis, E Buitenwerf, A S Cents, N Engels, J L J Hanssen, A J Meinders, F P N Mollema, L Nagelmaker, M L M van Doorn-Schepens, P Thomopoulos, M Timmer, B van der Wiel
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction A major knowledge gap in the treatment of complicated Staphylococcus aureus bacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of
Externí odkaz:
https://doaj.org/article/cf2fa20a75a4412a9dbd8b21a6ce2c68
Autor:
DTP Buis, CH van Werkhoven, MA van Agtmael, HI Bax, M Berrevoets, MGJ de Boer, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, LBS Gelinck, E Jong, AJJ Lammers, JTM Van der Meer, JJ Oosterheert, E Sieswerda, R Soetekouw, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, JM Prins, KCE Sigaloff
Publikováno v:
BMJ open, 13(4):e068295. BMJ Publishing Group
BMJ Open, 13(4):e068295, 1-26. BMJ Publishing Group
Collaborators SAFE-trial study group 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. e068295 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4). BMJ Publishing Group
BMJ Open, 13(4):e068295. BMJ Publishing Group
Buis, D T P, Van Werkhoven, C H, Van Agtmael, M A, Bax, H I, Berrevoets, M, De Boer, M G J, Bonten, M J M, Bosmans, J E, Branger, J, Douiyeb, S, Gelinck, L B S, Jong, E, Lammers, A J J, Van Der Meer, J T M, Oosterheert, J J, Sieswerda, E, Soetekouw, R, Stalenhoef, J E, Van Der Vaart, T W, Bij De Vaate, E A, Verkaik, N J, Van Vonderen, M G A, De Vries, P J, Prins, J M & Sigaloff, K C E 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. 1-26 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4):e068295, 1-26. BMJ Publishing Group
Collaborators SAFE-trial study group 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. e068295 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4). BMJ Publishing Group
BMJ Open, 13(4):e068295. BMJ Publishing Group
Buis, D T P, Van Werkhoven, C H, Van Agtmael, M A, Bax, H I, Berrevoets, M, De Boer, M G J, Bonten, M J M, Bosmans, J E, Branger, J, Douiyeb, S, Gelinck, L B S, Jong, E, Lammers, A J J, Van Der Meer, J T M, Oosterheert, J J, Sieswerda, E, Soetekouw, R, Stalenhoef, J E, Van Der Vaart, T W, Bij De Vaate, E A, Verkaik, N J, Van Vonderen, M G A, De Vries, P J, Prins, J M & Sigaloff, K C E 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. 1-26 . https://doi.org/10.1136/bmjopen-2022-068295
IntroductionA major knowledge gap in the treatment of complicatedStaphylococcus aureusbacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21151bb8a9b51016d71c3255ece501
https://pure.amc.nl/en/publications/safe-shortening-of-antibiotic-treatment-duration-for-complicated-staphylococcus-aureus-bacteraemia-safe-trial(7669693a-f906-448b-b63f-7135141cbf37).html
https://pure.amc.nl/en/publications/safe-shortening-of-antibiotic-treatment-duration-for-complicated-staphylococcus-aureus-bacteraemia-safe-trial(7669693a-f906-448b-b63f-7135141cbf37).html
Autor:
Hensley KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, Mueller YM, Dalm VASH, Papageorgiou G, Steggink H, Gorska A, Bogers S, den Hollander JG, Bierman WFW, Gelinck LBS, Schippers EF, Ammerlaan HSM, van der Valk M, van Vonderen MGA, Delsing CE, Gisolf EH, Bruns AHW, Lauw FN, Berrevoets MAH, Sigaloff KCE, Soetekouw R, Branger J, de Mast Q, Lammers AJJ, Lowe SH, de Vries RD, Katsikis PD, Rijnders BJA, Brinkman K, Roukens AHE, Rokx C
Publikováno v:
PLoS medicine [PLoS Med] 2023 Jan 06; Vol. 20 (1), pp. e1004159. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2023).
Autor:
Hensley KS; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, Netherlands., Jongkees MJ; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, Netherlands., Geers D; Department of Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands., Mueller YM; Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands., Dalm VASH; Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands.; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands., Papageorgiou G; Department of Biostatistics, Erasmus University Medical Centre, Rotterdam, Netherlands., Steggink H; Department of Internal Medicine and Infectious Diseases, OLVG Hospital, Amsterdam, Netherlands., Gorska A; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, Netherlands., Bogers S; Department of Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands., den Hollander JG; Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands., Bierman WFW; Department of Internal Medicine, Section Infectious Diseases, University of Groningen, Groningen, Netherlands., Gelinck LBS; Department of Internal Medicine and Infectious Diseases, Haaglanden Medical Centre, The Hague, Netherlands., Schippers EF; Department of Internal Medicine, Haga Teaching Hospital, The Hague, Netherlands.; Department of Infectious Diseases, Leiden University Medical Centre, Leiden Netherlands., Ammerlaan HSM; Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands., van der Valk M; Department of Internal Medicine and Infectious Diseases, DC Klinieken, Amsterdam, Netherlands.; Department of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands., van Vonderen MGA; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, Netherlands., Delsing CE; Department of Internal Medicine and Infectious Diseases, Medisch Spectrum Twente, Enschede, Netherlands., Gisolf EH; Department of Internal Medicine and Infectious Diseases, Rijnstate Hospital, Arnhem, Netherlands., Bruns AHW; Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht, Utrecht, Netherlands., Lauw FN; Department of Internal Medicine and Infectious Diseases, Medical Centre Jan van Goyen, Amsterdam, Netherlands., Berrevoets MAH; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, Netherlands., Sigaloff KCE; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Soetekouw R; Department of Internal Medicine and Infectious Diseases, Spaarne Gasthuis, Haarlem, Netherlands., Branger J; Department of Internal Medicine, Flevo Hospital, Almere, Netherlands., de Mast Q; Department of Internal Medicine, Radboud Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, Netherlands., Lammers AJJ; Department of Internal Medicine and Infectious Diseases, Isala Hospital, Zwolle, Netherlands., Lowe SH; Department of Internal Medicine and Infectious Diseases, Maastricht University Medical Centre, Maastricht, Netherlands., de Vries RD; Department of Viroscience, Erasmus University Medical Centre, Rotterdam, Netherlands., Katsikis PD; Department of Immunology, Erasmus University Medical Centre, Rotterdam, Netherlands., Rijnders BJA; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, Netherlands., Brinkman K; Department of Internal Medicine and Infectious Diseases, OLVG Hospital, Amsterdam, Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University Medical Centre, Leiden Netherlands., Rokx C; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, Netherlands.
Publikováno v:
PLoS medicine [PLoS Med] 2022 Oct 27; Vol. 19 (10), pp. e1003979. Date of Electronic Publication: 2022 Oct 27 (Print Publication: 2022).
Autor:
Scheper H; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands., van der Wal RJP; Department of Orthopaedics, Leiden University Medical Centre, Leiden, The Netherlands., Mahdad R; Department of Orthopaedic Surgery, Alrijne Hospital, Leiderdorp, The Netherlands., Keizer S; Department of Orthopaedic Surgery, Haaglanden Medical Centre, The Hague, The Netherlands., Delfos NM; Department of Infectious Diseases, Alrijne Hospital, Leiderdorp, The Netherlands., van der Lugt JCT; Department of Orthopaedic Surgery, Reinier Haga Orthopedic Center, The Hague, The Netherlands., Veldkamp KE; Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands., Nolte PA; Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands., Leendertse M; Department of Medical Microbiology, Alrijne Hospital, Leiderdorp, The Netherlands., Gelinck LBS; Department of Internal Medicine, Haaglanden Medical Centre, The Hague, The Netherlands., Mollema FPN; Department of Internal Medicine, Haaglanden Medical Centre, The Hague, The Netherlands., Schippers EF; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Internal Medicine, Haga Teaching Hospital, The Hague, The Netherlands., Wattel-Louis HG; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands., Nelissen RGHH; Department of Orthopaedics, Leiden University Medical Centre, Leiden, The Netherlands., de Boer MGJ; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Sep 13; Vol. 9 (10), pp. ofac474. Date of Electronic Publication: 2022 Sep 13 (Print Publication: 2022).
Autor:
Willems SA; Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands., Buntinx M; Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands., Gelinck LBS; Department of Internal Medicine, Haaglanden Medical Centre, The Hague, The Netherlands., van Schaik J; Department of Vascular Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Eefting D; Department of Surgery, Haaglanden Medical Centre, The Hague, The Netherlands.; Department of Vascular Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
Publikováno v:
EJVES vascular forum [EJVES Vasc Forum] 2021 Jul 14; Vol. 52, pp. 26-29. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
Autor:
Brinkman TK; Haaglanden Medisch Centrum, locatie Westeinde, afd. Interne Geneeskunde/Maag-darm-lever, Den Haag.; Contact: T. K. Brinkman (brinkman.tk@gmail.com)., Hubers AAM; Haaglanden Medisch Centrum, locatie Westeinde, afd. Interne Geneeskunde/Maag-darm-lever, Den Haag., van der Veek PPJ; Haaglanden Medisch Centrum, locatie Westeinde, afd. Interne Geneeskunde/Maag-darm-lever, Den Haag., Scholten EM; Haaglanden Medisch Centrum, locatie Westeinde, afd. Interne Geneeskunde/Maag-darm-lever, Den Haag., Gelinck LBS; Haaglanden Medisch Centrum, locatie Westeinde, afd. Interne Geneeskunde/Maag-darm-lever, Den Haag.
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2020 Nov 23; Vol. 164. Date of Electronic Publication: 2020 Nov 23.
Autor:
Dekker TJA; Haaglanden Medisch Centrum, afd. Interne Geneeskunde,Den Haag.; Contact: Tim J.A. Dekker (t.j.a.dekker@gmail.com)., Muller AE; Haaglanden Medisch Centrum, afd. Medische Microbiologie,Den Haag., Gelinck LBS; Haaglanden Medisch Centrum, afd. Interne Geneeskunde,Den Haag.
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2020 Oct 12; Vol. 164. Date of Electronic Publication: 2020 Oct 12.
Autor:
Dautzenberg MJD; 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.; 2Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; 3Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Bayjanov JR; 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., Leverstein-van Hall MA; Department of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands.; 5Department of Medical Microbiology, Alrijne Hospital, Leiden, the Netherlands., Muller AE; Department of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Gelinck LBS; Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands., Jansen CL; Department of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Leyten EMS; Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands., Ruys T; Department of Intensive Care Medicine, Haaglanden Medisch Centrum, The Hague, the Netherlands., Scharringa J; 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., van der Starre RE; Department of Medical Microbiology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Fluit AC; 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., Bonten MJM; 1Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.; 2Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2018 May 22; Vol. 7, pp. 67. Date of Electronic Publication: 2018 May 22 (Print Publication: 2018).
Autor:
Heitz AFN; Department of Internal Medicine, Haaglanden Medical Centre, The Hague, the Netherlands., Hofstee HMA, Gelinck LBS, Puylaert JB
Publikováno v:
The Netherlands journal of medicine [Neth J Med] 2017 Oct; Vol. 75 (8), pp. 351-353.